Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study
Why the study?
HI-PEITHO was designed to establish the first-line treatment in intermediate-high risk pulmonary embolism patients with imminent hemodynamic collapse and inform international guidelines.
Does ultrasound-facilitated, catheter-directed thrombolysis improve outcomes compared to anticoagulation alone in patients with acute intermediate-high-risk pulmonary embolism?
Population
Intermediate-high risk PE patients with imminent hemodynamic collapse
Comparison
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone
Design
Trial rationale and design
Authors
Discussion
Loading...
Member takes
Implication
The HI-PEITHO study is designed to evaluate ultrasound-facilitated, catheter-directed thrombolysis versus anticoagulation alone to establish first-line treatment for intermediate-high risk pulmonary embolism.
Key Points
- This research aims to determine the most effective treatment for patients with acute intermediate-high-risk pulmonary embolism.
- Randomized trial design comparing catheter-directed thrombolysis with anticoagulation alone.
- Involves patients at risk of hemodynamic collapse due to pulmonary embolism.
- Expected to inform future treatment guidelines and evaluation of therapy options.
- The trial aims to establish a preferred treatment approach for high-risk pulmonary embolism patients.
- Outcomes will influence international guidelines for pulmonary embolism management.
Structured PICO
Does ultrasound-facilitated, catheter-directed thrombolysis improve outcomes compared to anticoagulation alone in patients with acute intermediate-high-risk pulmonary embolism?
P
Population
Patients with acute intermediate-high-risk pulmonary embolism with imminent hemodynamic collapse
I
Intervention
Ultrasound-facilitated, catheter-directed thrombolysis
C
Comparator
Anticoagulation alone
The HI-PEITHO study is designed to evaluate ultrasound-facilitated, catheter-directed thrombolysis versus anticoagulation alone to establish first-line treatment for intermediate-high risk pulmonary embolism.
Cite This Study
Klok et al. (2022) studied this question.